Morag Farquhar1, Irene J Higginson, Petrea Fagan, Sara Booth. 1. Macmillan Post Doctoral Research Fellow, University of Cambridge, General Practice and Primary Care Research Unit, Department of Public Health & Primary Care, Institute of Public Health, Cambridge, England. mcf22@medschl.cam.ac.uk
Abstract
OBJECTIVE: Breathlessness is the most common devastating symptom of advanced chronic obstructive pulmonary disease (COPD). The Breathlessness Intervention Service (BIS) is a multidisciplinary service that uses both pharmacological and non-pharmacological evidence-based interventions to reduce the impact of the symptom. The results of a Phase II evaluation of the service are reported. METHOD: Pretest - posttest analysis of non-randomized data was performed for 13 patients with severe advanced COPD referred to BIS. RESULTS: Mean VAS-Distress scores (primary outcome measure) decreased (improved) for the group between baseline and follow up suggesting a clinically significant improvement: 6.88 (SD = 2.50) to 5.25 (SD = 2.99). At an individual level, 11 of the 13 patients showed a decrease in their distress due to breathlessness, and for eight of these this was clinically significant (range of all decreases 0.3-7.1 cm). Changes in secondary outcome measures are also reported. SIGNIFICANCE OF RESULTS: The Breathlessness Intervention Service appears to reduce distress due to breathlessness among patients with advanced COPD. A Phase III fully-powered randomized controlled trial is warranted.
OBJECTIVE:Breathlessness is the most common devastating symptom of advanced chronic obstructive pulmonary disease (COPD). The Breathlessness Intervention Service (BIS) is a multidisciplinary service that uses both pharmacological and non-pharmacological evidence-based interventions to reduce the impact of the symptom. The results of a Phase II evaluation of the service are reported. METHOD: Pretest - posttest analysis of non-randomized data was performed for 13 patients with severe advanced COPD referred to BIS. RESULTS: Mean VAS-Distress scores (primary outcome measure) decreased (improved) for the group between baseline and follow up suggesting a clinically significant improvement: 6.88 (SD = 2.50) to 5.25 (SD = 2.99). At an individual level, 11 of the 13 patients showed a decrease in their distress due to breathlessness, and for eight of these this was clinically significant (range of all decreases 0.3-7.1 cm). Changes in secondary outcome measures are also reported. SIGNIFICANCE OF RESULTS: The Breathlessness Intervention Service appears to reduce distress due to breathlessness among patients with advanced COPD. A Phase III fully-powered randomized controlled trial is warranted.
Authors: Anand S Iyer; Surya P Bhatt; Jeffrey J Garner; J Michael Wells; Jennifer L Trevor; Neha M Patel; deNay Kirkpatrick; John C Williams; Mark T Dransfield Journal: Ann Am Thorac Soc Date: 2016-02
Authors: Morag C Farquhar; A Toby Prevost; Paul McCrone; Irene J Higginson; Jennifer Gray; Barbara Brafman-Kennedy; Sara Booth Journal: Trials Date: 2011-05-20 Impact factor: 2.279
Authors: Morag C Farquhar; A Toby Prevost; Paul McCrone; Barbara Brafman-Price; Allison Bentley; Irene J Higginson; Chris Todd; Sara Booth Journal: BMC Med Date: 2014-10-31 Impact factor: 8.775
Authors: Morag C Farquhar; A Toby Prevost; Paul McCrone; Barbara Brafman-Price; Allison Bentley; Irene J Higginson; Chris J Todd; Sara Booth Journal: Trials Date: 2016-04-04 Impact factor: 2.279